BSECompany Update6d ago · 27 Oct 2026, 02:53 pm

Appointment of Mr Chan Sing En as an Independent Director of FMV Global Innovations Pte.Ltd, Singapore, a Material Wholly Owned Subsidiary Company

Fischer Medical Ventures Ltd · 524743

✦ AI SummaryMgmt Change

Fischer Medical Ventures Ltd has appointed Mr. Chan Sing En as an Independent Director on the Board of Directors of FMV Global Innovations Pte. Ltd., a material wholly owned subsidiary company, with effect from October 27, 2026.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fischer Medical Ventures Ltd - 524743 - Appointment Of Independent Director On The Board Of Material Wholly Owned Subsidiary Company

Attachments (1)

📄

84c90a9d-beab-4d28-82d3-795afd7d5887.pdf

pdf

Download →
View document text
FISCHER MEDICAL VENTURES LIMITED Registered Office Address: Survey No. 480/2 AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548 October 27, 2026 To To BSE Limited National Stock Exchange of India Ltd. Corporate Relationship Department Exchange Plaza, 5tll floor 25th Floor, P J Towers Plot No. C/ 1, G Block, Dalal Street, Fort, Bandra-Kurla Complex Bandra (E), Mumbai – 400 001 Mumbai - 400 051 BSE Scrip Code: 524743 NSE Symbol: FISCHER Dear Sir/ Madam, Subject: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 24(1) read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Chan Sing En has been appointed as an Independent Director on the Board of Directors of FMV Global Innovations Pte. Ltd., Singapore, an unlisted material wholly owned subsidiary of the Company, with effect from 27.10.2026 (Today). Details as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 are enclosed herewith as Annexure-1. The above appointment is in accordance with the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is submitted for your information and records. Thanking you, Yours Truly, For FISCHER MEDICAL VENTURES LIMITED BALAJI GANDLA COMPANY SECRETARY AND COMPLIANCE OFFICER Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006 FISCHER MEDICAL VENTURES LIMITED Registered Office Address: Survey No. 480/2 AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548 Annexure-1 Details under Regulation 30 of the Listing Regulations read with SEBI Circular No. EBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023. Name MR. CHAN SING EN DIN 11300541 Reason for change viz. Appointment of Mr. Chan Sing En (DIN: 11300541), as a common appointment, reappointment, Independent Director of the material wholly owned subsidiary of the resignation, removal, death Company- FMV Global Innovations Pte. Ltd., Singapore. or otherwise Date of appointment/re- 27-10-2026 appointment/cessation (as applicable) & term of appointment/reappointment Term of As per the resolution passed in accordance with the laws of Singapore. appointment/reappointment Brief profile (in case of Mr. Chan Sing En is a dynamic investment professional with over three appointment) decades of experience spanning Southeast Asia and Australia. He has built a distinguished career in private equity, corporate finance, and operational turnarounds, consistently driving growth and value creation across diverse industries. His deep understanding of financial structuring and market strategy has enabled numerous successful business revitalizations and investor partnerships. As Principal and Director of SovCapital Pte Ltd, Singapore, Mr. Chan leads strategic investment and restructuring initiatives for both private and public companies. He specializes in reverse takeovers, capital raising, and pre-IPO consultancy, offering seasoned guidance to founders and executives. His leadership is marked by a hands-on approach that combines strategic foresight with operational precision. In addition, Mr. Chan serves on the advisory board of FTAG Investment Bank in Malaysia, contributing to high-profile corporate finance transactions and cross-border deals, including the NASDAQ listing of a global supercar brand. A graduate of Pepperdine University, USA, with a degree in Business Administration, he continues to bring financial acumen, boardroom experience, and visionary leadership to every engagement. Disclosure of relationships Mr. Chan Sing En is not related to any of the Directors of the Company. between Directors Information as required Mr. Chan Sing En is not debarred from holding the office of Director by pursuant to BSE Circular ref. virtue of any SEBI Order or any such authority no. LIST/COMP/14/2018-19 and NSE ref. no. NSE/ML/2018/24 dated June 20, 2018. Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006